Sue Gail Eckhardt

Companies

• ExelixisBoard member Jan 9, 2024 to now¹
• Syros Pharmaceuticals, Inc.Board member Sep 9, 2020 to Jun 7, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Exelixis EXEL16,079 shares³$1.0M at $62.23Jun 1, 2026
• SPSyros Pharmaceuticals, Inc.16,000 shares⁴Jun 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 1, 2026Sold 9,812 shares at $50.14 of Exelixis³
• May 27, 2026Granted 8,367 shares of Exelixis⁵
• Feb 13, 2026Sold 3,856 shares at $43.79 of Exelixis⁶
• Jun 2, 2025Sold 4 shares at $43.67 of Exelixis⁷
• Jun 2, 2025Sold 18,834 shares at $42.74 of Exelixis⁷
• May 29, 2025Granted 9,812 shares of Exelixis⁸
• Feb 14, 2025Sold 3,856 shares at $35.04 of Exelixis⁹
• Feb 14, 2025Sold 7,712 shares at $35.01 of Exelixis⁹
• Feb 14, 2025Exercised options 7,712 shares at $23.24 of Exelixis⁹
• Jun 5, 2024Granted 4,000 shares of Syros Pharmaceuticals, Inc.⁴
• May 31, 2024Granted 18,838 shares of Exelixis¹⁰
• Jan 5, 2024Granted 15,424 shares of Exelixis¹¹
• Jun 1, 2023Granted 4,000 shares of Syros Pharmaceuticals, Inc.¹²
• Sep 16, 2022Granted 8,000 shares of Syros Pharmaceuticals, Inc.¹³